antibiotik juni 2008

Upload: sylvia-nur-kartika

Post on 03-Apr-2018

225 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/28/2019 Antibiotik Juni 2008

    1/45

    Antibiotic Therapy

    Identify infecting organism

    Evaluate drug sensitivity

    Target site of infection

    Drug safety/side effect profile

    Patient factors

    Cost

  • 7/28/2019 Antibiotik Juni 2008

    2/45

    Classification of Antibiotics

    Bacteriostatic Bactericidal

  • 7/28/2019 Antibiotik Juni 2008

    3/45

    Classification of Antibiotics

    Chemical Structure

    Spectrum of ActivityMechanism of Action

  • 7/28/2019 Antibiotik Juni 2008

    4/45

    Mechanism of Action

  • 7/28/2019 Antibiotik Juni 2008

    5/45

    Inhibitors of Cell Wall Synthesis

  • 7/28/2019 Antibiotik Juni 2008

    6/45

  • 7/28/2019 Antibiotik Juni 2008

    7/45

    Beta Lactam Antibiotics

    Penicillins

    Cephalosporins

    Carbapenems

    Monobactams

  • 7/28/2019 Antibiotik Juni 2008

    8/45

    Penicllins

    Derived from the fungus Penicillium

    Therapeutic concentration in most tissuesPoor CSF penetration

    Renal excretion

    Side effects: hypersensitivity, nephritis,neruotoxicity, platelet dysfunction

  • 7/28/2019 Antibiotik Juni 2008

    9/45

    Natural Penicillins

    Penicillin G, Penicillin V

  • 7/28/2019 Antibiotik Juni 2008

    10/45

    Antistaphylococcal Penicillins

    Methicillin

    Nafcillin

    Oxacillin

    Dicloxacillin

  • 7/28/2019 Antibiotik Juni 2008

    11/45

    Aminopenicillins

    Amoxicillin +/- clavulanate

    Ampicillin +/- sulbactam

  • 7/28/2019 Antibiotik Juni 2008

    12/45

    Antipseudomonal Penicillins

    Carbenicillin

    Ticarcillin +/- clavulanate

    Piperacillin +/- tazobactam

  • 7/28/2019 Antibiotik Juni 2008

    13/45

    Cephalosporins

    Structurally similar topenicillins

    Therapeutic

    concentration in manytissues, 3rd and 4thgeneration into CSF

    Renal Excretion

    Side Effects allergy

    disulfiram-like effect

    anti-Vitamin K

  • 7/28/2019 Antibiotik Juni 2008

    14/45

    Generations of Cephalosporins

  • 7/28/2019 Antibiotik Juni 2008

    15/45

    Monobactams

    Aztreonam

    single beta lactam ring

    narrow spectrum:gram-negative aerobes

    Enterobacteriacea

    Pseudomonas

    given IV/IM

    renal excretion

    little cross-reactivitywith other beta lactams

    side effects: phlebitis,rash, elevated LFTs

  • 7/28/2019 Antibiotik Juni 2008

    16/45

    Carbapenems

    Meropenem/Imipenem

    broad spectrum

    active against MRSA

    given IV

    penetrates CSF

    renal metabolism and

    excretionaddition of cilastin

    side effects: GI upset,eosinophilia, neutropenia,

    lowering of seizure threshold

  • 7/28/2019 Antibiotik Juni 2008

    17/45

    Vancomycin

    Tricyclic glycopeptide

    Inhibits synthesis of phospholipids and

    cross-linking of peptidoglycansActivity against gram-positive organisms

    Useful for beta lactam resistant infections

    Widely distributed, penetrates CSFRenal elimination, follows creatinine cl.

    Side effects: phlebitis, red man syndrome,

    ototoxicity, nephrotoxicity

  • 7/28/2019 Antibiotik Juni 2008

    18/45

    Protein Synthesis Inhibitors

    Human Ribosome

    80S 40S

    60S

    Bacterial Ribosome

    70S 30S

    50S

  • 7/28/2019 Antibiotik Juni 2008

    19/45

    Tetracyclines

    Isolated from Streptomyces aureofaciens

    Reversibly bind 30S ribosomal subunit

    Penetrate sinus mucosa, saliva and tears

    Metabolized in liver-->excreted in bile-->reabsorbed-->eliminated in urine

    Side effects: GI upset, hepatotoxicity,photosensitivity, bony deposition

    Contraindicated in pregnant or breast

    feeding women, children under 8 y/o

  • 7/28/2019 Antibiotik Juni 2008

    20/45

    Tetracyclines

  • 7/28/2019 Antibiotik Juni 2008

    21/45

    Aminoglycosides

    Derived from Streptomyces and Micormonospora

    Irreversible binding to 30S subunit

    Actively transported into bacterial cellsVariable tissue penetration, unreliable CSF levels

    Concentrate within perilymph

    Renal eliminationNephrotoxicity, ototoxicity, neurotoxicity

  • 7/28/2019 Antibiotik Juni 2008

    22/45

    Aminoglycosides

  • 7/28/2019 Antibiotik Juni 2008

    23/45

    Macrolides

    Macrocyclic lactone structure

    Irreversible binding to 50S subunit

    Therapeutic concentrations inoropharyngeal and respiratory secretions

    No CSF penetration

    Metabolized in liver, excreted in feces andurine

    Side effects: GI upset, ototoxicity,

    hepatotoxicity

  • 7/28/2019 Antibiotik Juni 2008

    24/45

    Erythromycin

  • 7/28/2019 Antibiotik Juni 2008

    25/45

    Alternate Macrolides

    Clarithromycin Azithromycin

  • 7/28/2019 Antibiotik Juni 2008

    26/45

    Chloramphenicol

    Isolated from Streptomyces

    Reversible binding to 50S subunit

    Broad spectrum of activityIndicated for severe anaerobic infections or

    unresponsive life-threatening infections

    Widely distributed, enters CSF

    Metabolized in liver (inhibits P-450), eliminatedin urine

    Toxicities: reversible anemia, hemolytic anemia,

    aplastic anemia, gray baby syndrome

  • 7/28/2019 Antibiotik Juni 2008

    27/45

    Clindamycin

    Semisynthetic derivative of Lincomycin

    Irreversible binding to 50S subunit

    Covers anaerobes and gram + aerobes

    Widely useful for head and neck infections

    Penetrates saliva, sputum, pleural fluid, and bone,but not CSF

    Metabolized in liver-->reabsorbed-->eliminated inurine

    Side effects: rash, neutropenia/thrombocytopenia,

    pseudomembranous colitis

  • 7/28/2019 Antibiotik Juni 2008

    28/45

    Inhibitors of Metabolism

    Sulfonamides

    Trimethoprim

    Interfere with theproduction of folicacid coenzymes that

    are required forpurine and pyrimidinesynthesis

  • 7/28/2019 Antibiotik Juni 2008

    29/45

    Sulfonamides

    Derived from prontosil

    Competitve antagonist ofPABA

    Wide distribution, penetrateCSF, cross placenta

    Metabolized in liver,eliminated in urine

    Side effects: rash,angioedema, Stevens-Johnson syndrome,kernicterus

    Avoid in pregnancy andinfants

  • 7/28/2019 Antibiotik Juni 2008

    30/45

    Sulfonamides

  • 7/28/2019 Antibiotik Juni 2008

    31/45

    Trimethoprim

    Inhibits dihydrofolate reductase

    1000x higher affinity for bacterial enzyme

    than human enzymeSimilar spectrum and pharmacokinetic

    profile as sulfas

    Side effects: folate deficiency anemia,leukopenia, granulocytopenia

  • 7/28/2019 Antibiotik Juni 2008

    32/45

    Co-Trimoxazole (TMP/SMX)

    Combination gives synergistic antibacterialaction

  • 7/28/2019 Antibiotik Juni 2008

    33/45

    Co-Trimoxazole (TMP/SMX)

    I hibit f N l i A id

  • 7/28/2019 Antibiotik Juni 2008

    34/45

    Inhibitors of Nucleic Acid

    Function/Synthesis

    Fluoroquinolones

    Bind bacteria DNA gyrase (topoisomerase II)

    Concentrate in sinus and middle ear mucosa,penetrate cartilage and bone

    Partially metabolized in liver-->GI or renal excretion

    Side effects: nausea, dizziness, phototoxicity,nephrotoxicity

    Avoid in pregnant or nursing women

    ? Use in children--possible effect on articularcartilage

  • 7/28/2019 Antibiotik Juni 2008

    35/45

    Fluoroquinolones

  • 7/28/2019 Antibiotik Juni 2008

    36/45

  • 7/28/2019 Antibiotik Juni 2008

    37/45

    Antimycobacterial Therapy

    Must address two distinct populations oftubercle bacilli

    First-line treatment: regimens of 3-4drugs for 6 months to 2 years

    Second-line therapy: reserved for multi-

    drug resistant organisms or unresponsiveinfection

  • 7/28/2019 Antibiotik Juni 2008

    38/45

  • 7/28/2019 Antibiotik Juni 2008

    39/45

    First-Line Agents

    Isoniazide

    Rifampin

    PyrazinamideEthambutol

    Streptomycin

    Isoniazide

    most potent drug

    inhibits formation of

    outer mycolic acidwidely distributes and

    penetrates CSF

    metabolized in liver,

    excreted in urine,saliva, and sputum

    side effects:hypersensitivity,neuropathy,hepatotoxicity

  • 7/28/2019 Antibiotik Juni 2008

    40/45

    First-Line Agents

    Isoniazide

    Rifampin

    PyrazinamideEthambutol

    Streptomycin

    Rifampinfrom Streptomyces

    antibacterial and anti-tubercule

    interferes with RNAtranscription

    wide distribution, penetratesCSF

    metabolized in livergives orange-red color to

    stool, urine and tears

    side effects: rash, GI upset,hepatotoxicity

  • 7/28/2019 Antibiotik Juni 2008

    41/45

    First-Line Agents

    Isoniazide

    Rifampin

    PyrazinamideEthambutol

    Streptomycin

    Pyrazinamide

    hydrolyzed topyrazinoic acid

    unclear mechanism

    widely distributed,including CSF

    side effects: GIupset, hepatotoxicity,hyperuricemia

  • 7/28/2019 Antibiotik Juni 2008

    42/45

    First-Line Agents

    Isoniazide

    Rifampin

    PyrazinamideEthambutol

    Streptomycin

    Ethambutol

    inhibits cell wallsynthesis and

    maintenance

    widely distributed,penetrates CSF

    partially metabolized,

    excreted in urine

    potential for opticneuritis

  • 7/28/2019 Antibiotik Juni 2008

    43/45

    First-Line Agents

    Isoniazide

    Rifampin

    PyrazinamideEthambutol

    Streptomycin

    Streptomycin

    aminoglycoside

    binds 30S subunit

    penetrates synovial,pleural, pericardial, andascitic fluids but not CSF

    renal excretion

    side effects:hypersensitivity,paraesthesias, auditoryor vestibular dysfunction,nephrotoxicity

  • 7/28/2019 Antibiotik Juni 2008

    44/45

    Antimycobacterials for Leprosy

    Dapsonestructurally related to

    sulfonamides

    PABA antagonist

    activity against M. leprae

    also effective forpneumocystis and brownrecluse spider bites

    wide distribution

    acetylated in liver, eliminatedin urine

    side effects: erythemanodosum leprosum,

    peripheral neuropathy,methemoglobinemia

    Clofaziminesynthetic phenazine dye

    binds DNA and inhibitsreplication and transcription

    activity against M. leprai andMAI

    wide distribution, does notpenetrate CSF

    partially metabolized,excreted in bile

    side effects: GI upset,red/purple discoloration ofskin and body fluids

  • 7/28/2019 Antibiotik Juni 2008

    45/45

    Antibiotic Prophylaxis

    Post-op wound infection is the second mostcommon nosocomial infection.

    Cost of this complication approaches $5billion annually.

    Prolongs hospital length of stay by 15 days.

    Costs nearly $22,000 more for one post-opwound infection that to use prophylacticclindamycin on 100 patients.